Vantage Consulting Group’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-505
Closed -$257K 173
2024
Q2
$257K Sell
505
-29
-5% -$14.2K 0.19% 90
2024
Q1
$264K Buy
534
+79
+17% +$40.2K 0.17% 91
2023
Q4
$240K Sell
455
-91
-17% -$48.5K 0.16% 143
2023
Q3
$275K Buy
546
+21
+4% +$10.3K 0.18% 95
2023
Q2
$252K Sell
525
-64
-11% -$31.3K 0.15% 120
2023
Q1
$278K Buy
589
+78
+15% +$37.6K 0.16% 93
2022
Q4
$271K Sell
511
-48
-9% -$25.4K 0.16% 94
2022
Q3
$282K Sell
559
-2
-0.4% -$1.05K 0.16% 89
2022
Q2
$288K Buy
561
+23
+4% +$11.6K 0.16% 90
2022
Q1
$274K Sell
538
-233
-30% -$112K 0.11% 102
2021
Q4
$387K Sell
771
-85
-10% -$38.5K 0.1% 69
2021
Q3
$334K Buy
856
+166
+24% +$68.8K 0.07% 77
2021
Q2
$276K Buy
690
+153
+28% +$61K 0.05% 95
2021
Q1
$200K Buy
537
+158
+42% +$54.7K 0.04% 90
2020
Q4
$133K Buy
+379
New +$127K 0.01% 96

Other funds holding UNH

Vantage Consulting Group's UNH Position: Q3 2024 in Review

Vantage Consulting Group sold out of UnitedHealth (UNH) in Q3 2024, closing a stake of 505 shares — an estimated $257K sold.

Vantage Consulting Group first reported a position in UNH in Q4 2020 and held it in 15 quarters. The position peaked at $387K in Q4 2021. 3,465 funds tracked by Wall St. Rank hold UNH as of Q3 2024.

  • Vantage Consulting Group reported no remaining UnitedHealth position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 505 UnitedHealth shares in Q3 2024, an estimated $257K.
  • Vantage Consulting Group first reported a position in UnitedHealth in Q4 2020 and held it in 15 quarters.
  • Vantage Consulting Group's UnitedHealth position peaked at $387K in Q4 2021.
  • 3,465 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.